Dear colleagues,   Prof. Dirk Strunk from the Cell Therapy Institute at the Paracelsus Medical University in Salzburg, Austria, and Director R&D at the Austrian Red Cross Research, will give a guest lecture at Fraunhofer IZI. You are very welcome to join the event. He will speak about:   “Cell-based regenerative therapies: EV or not […]

Tools and Technologies for Cell Therapy: From Platforms to Lipid Nanoparticles Advanced cell therapies are reshaping the future of medicine—bringing new hope to patients with hard-to-treat diseases. Yet, making these therapies accessible to more people remains a significant challenge. Complex workflows, manufacturing variability, and the need for scalable solutions demand continuous scientific and technological innovation. […]

Biofire® Mycoplasma Demo Die Firma Biomerieux, Herstellerin von Nachweissystemen für die mikrobiologische Qualitätskontrolle für (GMP-)Labore in der Bioproduktion und in der Zell- und Gentherapie veranstaltet einen Informationsnachmittag zur Vorstellung ihres weltweit einzigartigen, schnellsten und voll automatisierten PCR-basierten Mycoplasmentests. Die Gäste sind eingeladen, eine Live-Messung mitzuverfolgen und von unserem externen Partnerlabor ‚Labor LS‘ Gundlagen zur Validierung […]

Speaker: Dr. Christoph Conrad, Head of the Regulatory Support Unit from Berlin Institute of Health at Charité Universitätsmedizin (BIH) An overview of regulatory frameworks and submission strategies essential for the successful approval of gene and cell therapies in Europe and beyond.  

Speaker: Dr. Melissa van Pel, Head of Cell Therapy at NecstGen Explore the challenges of scaling up gene and cell therapy products and the critical role of Contract Development and Manufacturing Organizations (CDMOs). This lecture will focus on process development, and manufacturing strategies and models as applied in different countries. Registration open